A hacker identified by Lookonchain, responsible for the TLBL theft, spent 3.4 million Dai to buy 1,650 Ether just an hour before a November 11 update. This purchase occurred about three months after TLBL's private key was leaked, which compromised two wallets and caused losses exceeding $26 million. The incident highlights ongoing risks in digital asset security and the potential for stolen funds to be quickly moved or converted. Investors should stay alert to such activities as they indicate vulnerabilities in crypto asset protection.
The TLBL hacker's recent activity provides context for cryptocurrency market dynamics. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Nov 12, 2026 05:22 WIB: Among 50 major cryptocurrencies, 27 rose and 22 fell today. Balancer (BAL) gained 11.14% to Rp16.297 with a typical hold time of 85 days, while EOS (EOS.IO) rose 8.13% to Rp12.649 with an 87-day hold time. In contrast, Uniswap (UNI) dropped 3.70% to Rp117.501, with a typical hold time of 66 days and a Pluang order activity heavily skewed toward selling at 75%.
Ashland Inc.'s board of directors declared a quarterly cash dividend of $0.42 per share, payable on December 15, 2026, to shareholders of record as of December 1, 2026. This dividend reflects the company's ongoing commitment to returning value to sha...
AeroVironment secured a $405 million international order for its LOCUST X3 high-energy laser weapon systems, enhancing counter-drone defense capabilities in the Middle East amid rising regional security threats. Following the announcement, AeroVironm...
Vestas Wind Systems reported Q3 2026 earnings per share of $0.13 and revenue of $6.34 billion, both below analyst expectations. The company's profit was impacted by weak sales volume and a broken turbine blade. Following the earnings miss, Vestas' sh...
The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...
DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...
